Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019

• Autori principali: Anna Maisa (Autore), Christian Kollan (Autore), Matthias an der Heiden (Autore), Florian van Bömmel (Autore), Markus Cornberg (Autore), Stefan Mauss (Autore), Heiner Wedemeyer (Autore), Daniel Schmidt (Autore), Sandra Dudareva (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the trea...